Reine Allan Insider Trades

Insider Trading History

Track insider trading activity for Reine Allan. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Prime Medicine
Prime Medicine PRME
Chief Executive Officer
Holding Value $4.51M 1,300,000 shares
Last Trade
Feb 26, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.69M 1,300,000 shares
$4.38
$3.47
Prime Medicine
Prime Medicine PRME
Chief Executive Officer
Holding Value $2.95M 850,000 shares
Last Trade
Aug 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.43M 850,000 shares
$4.04
$3.47
Prime Medicine
Prime Medicine PRME
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Aug 01, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$3.43M 850,000 shares
$4.04
$3.47
Prime Medicine
Prime Medicine PRME
Chief Executive Officer
Holding Value $434k 125,000 shares
Last Trade
May 21, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$148k 125,000 shares
$1.18
$3.47
Prime Medicine
Prime Medicine PRME
Chief Executive Officer
Holding Value $6.94M 2,000,000 shares
Last Trade
May 19, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.68M 2,000,000 shares
$1.34
$3.47
Prime Medicine
Prime Medicine PRME
Chief Financial Officer
Holding Value $2.95M 850,000 shares
Last Trade
May 08, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$99k 75,000 shares
$1.32
$3.47
Prime Medicine
Prime Medicine PRME
Chief Financial Officer
Holding Value $954k 275,000 shares
Last Trade
Feb 27, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$666k 275,000 shares
$2.42
$3.47
Prime Medicine
Prime Medicine PRME
Chief Financial Officer
Holding Value $2.69M 775,000 shares
Last Trade
Dec 05, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$223k 75,000 shares
$2.97
$3.47
Prime Medicine
Prime Medicine PRME
Chief Financial Officer
Holding Value $347k 100,000 shares
Last Trade
May 17, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$680k 100,000 shares
$6.80
$3.47
Prime Medicine
Prime Medicine PRME
Chief Financial Officer
Holding Value $2.08M 600,000 shares
Last Trade
Jan 17, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.08M 600,000 shares
$6.80
$3.47
Foghorn Therapeutics
Foghorn Therapeutics FHTX
Director, Chief Financial Officer
Holding Value $337k 90,000 shares
Last Trade
Jan 26, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$754k 90,000 shares
$8.38
$3.74
Foghorn Therapeutics
Foghorn Therapeutics FHTX
Chief Financial Officer
Holding Value $505k 135,000 shares
Last Trade
Jan 26, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.01M 135,000 shares
$14.87
$3.74
Foghorn Therapeutics
Foghorn Therapeutics FHTX
Chief Financial Officer
Holding Value $963k 257,512 shares
Last Trade
Aug 09, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$226k 26,892 shares
$8.39
$3.74
Foghorn Therapeutics
Foghorn Therapeutics FHTX
Chief Financial Officer
Holding Value $449k 120,000 shares
Last Trade
Jan 28, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2M 120,000 shares
$16.63
$3.74
Foghorn Therapeutics
Foghorn Therapeutics FHTX
Chief Financial Officer
Holding Value $101k 26,892 shares
Last Trade
Oct 22, 2020 Sale
No data
No data
$3.74
Pieris Pharmaceuticals
Pieris Pharmaceuticals PIRS
Chief Financial Officer
Holding Value $2.21M 162,500 shares
Last Trade
Feb 26, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$40.2M 162,500 shares
$247.20
$13.60
Pieris Pharmaceuticals
Pieris Pharmaceuticals PIRS
Chief Financial Officer
Holding Value $732k 53,833 shares
Last Trade
Feb 20, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$71.1M 103,833 shares
$684.80
$13.60
Pieris Pharmaceuticals
Pieris Pharmaceuticals PIRS
See Remarks
Holding Value $884k 65,000 shares
Last Trade
Aug 17, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$7.41M 20,000 shares
$370.40
$13.60
Pieris Pharmaceuticals
Pieris Pharmaceuticals PIRS
See Remarks
Holding Value $612k 45,000 shares
Last Trade
Aug 16, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$17.1M 45,000 shares
$379.20
$13.60
Pieris Pharmaceuticals
Pieris Pharmaceuticals PIRS
See Remarks
Holding Value $6.12M 450,000 shares
Last Trade
Aug 09, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$180M 450,000 shares
$400.00
$13.60

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up